 |
competetive small molecule inhibitor of the enzyme O-GlcNAcase |
|---|---|
| Trade Name | |
| Orphan Indication | Progressive supranuclear palsy |
| USA Market Approval | USA |
| USA Designation Date | 2016-03-10 00:00:00 |
| Sponsor | Merck & Company, Inc.;126 East Lincoln Avenue, P. O. Box 2000;Rahway, New Jersey, 07065 |
